Study of the Follow-up of Stroke Treated With Anticoagulants (AOD)

University Hospital Center (CHU) Dijon Bourgogne

Status: Completed

Conditions: Stroke

Treatments: Drug: Anticoagulants

Study type: Observational

Funder types: Other

Identifiers

NCT03292575

Giroud 2016

Details and patient eligibility

About

Stroke is a major public health problem as it is very frequent (140,000 cases/year in France), and very serious (leading cause of death, 2nd leading cause of dementia, 3rd leading cause of handicap). Ischemic cardio-embolic stroke accounts for around 25% of ischemic strokes, and ischemic cardio-embolic stroke in a context of cardiac arrhythmia due to atrial fibrillation (CAAF) is the leading non-atheromatous cause. The aim of this study is to optimise the secondary prevention of CAAF-related stroke identified at the University Hospital of Dijon Burgundy in the framework of the recommendations of the '2010-2014 stroke plan' and the Compulsory Consultation at the 6th month (Directive DGOS//2015/262 of the 3rd August 2015)

Enrollment: 441 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients managed for stroke at the stroke unit of Dijon University Hospital for CAAF-related cardio-embolic stroke

Exclusion criteria

• NA

Trial design

441 participants in 1 patient group

Stroke related to CAAF

Treatment:

Drug: Anticoagulants